Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

COCH stock hub

Envoy Medical, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

COCHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

49.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

COCH

In the news

Latest news · COCH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All COCH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

191

Groups with data

Currency

USD

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001840877
Company name	Envoy Medical, Inc.
Country	United States
Country code	US
Cusip	29415V109
Employees	47
Employees Change	5%
Employees Change Percent	11.9
Enterprise value	$46.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US29415V1098
Last refreshed	2026-05-10
Market cap	$49.6M
Market cap category	Nano-Cap
Price	$0.65
Price currency	USD
Rev Per Employee	5,127.66x
Sector	Healthcare
Sic	3842
Symbol	COCH
Website	https://www.envoymedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-57.76%
EV Sales Forward	191.2x
EV/Sales	194.22x
FCF yield	-37.04%
P/S ratio	205.92x
PS Forward	202.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-183.82%
Gross Profit	$-443,000
Net Income	$-28.7M
Net Income Growth Years	0%
Pretax Margin	-9,857.26%
Profit Per Employee	$-609,830
ROA	-137.3
ROCE	735

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-57.42%
Cagr3y	-60%
Cagr5y	-41.88%
EPS Growth Quarters	2
EPS Growth Years	2
Revenue Growth	7.11x
Revenue Growth Q	78.57x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	0.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$8.6M
Cash	$3.7M
Current Assets	$6.3M
Current Liabilities	$11.6M
Debt	$919,000
Equity	$-11.8M
Interest Coverage	-13.89
Liabilities	$20.3M
Long Term Assets	$2.3M
Long Term Liabilities	$8.8M
Net Cash	$2.8M
Net Cash By Market Cap	$5.68
Tangible Book Value	$-11.8M
Tangible Book Value Per Share	$-0.41
WACC	16.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.54
Inventory Turnover	0.42
Net Working Capital	$-8.8M
Quick ratio	0.33
Working Capital	$-5.3M
Working Capital Turnover	$-0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-23.78%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-57.39%
200-day SMA	0.86
3Y total return	-93.6%
50-day SMA	0.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.37%
All Time High	11.72
All Time High Change	-94.49%
All Time High Date	2023-09-26
All Time Low	0.36
All Time Low Change	78.07%
All Time Low Date	2026-02-11
ATR	0.05
Beta	1.9
Beta1y	1.13
Beta2y	0.29
Ch YTD	-2.36
High	0.68
High52	1.91
High52 Date	2025-05-14
High52ch	-66.2%
Low	0.63
Low52	0.36
Low52 Date	2026-02-11
Low52ch	78.07%
Ma50ch	-8.14%
Premarket Change Percent	3.03
Premarket Price	$0.68
Premarket Volume	5,164
Price vs 200-day SMA	-25.14%
RSI	43.03
RSI Monthly	30.77
RSI Weekly	42.71
Sharpe ratio	0.01x
Sortino ratio	0.08
Total Return	-23.78%
Tr YTD	-2.36
Tr1m	-5.56%
Tr1w	-5.21%
Tr3m	36.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.14
Earnings Revenue Estimate	60,000x
Earnings Revenue Estimate Growth	30.43x
Operating Income	$-22.1M
Operating margin	-9,161.8
Price target	$6
Price Target Change	$830

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45,774,934%
Float Percent	59.54%
Net Borrowing	9,073,000
Shares Insiders	37.17%
Shares Institutions	3.6%
Shares Out	76,881,110
Shares Qo Q	30.29%
Shares Yo Y	23.78%
Short Float	2.82%
Short Ratio	3.7
Short Shares	1.68

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-19.1M
Average Volume	124,184.6x
Bv Per Share	-0.41
CAPEX	$-179,000
Ch1m	-5.56
Ch1w	-5.21
Ch1y	-57.39
Ch3m	36.9
Ch3y	-93.6
Ch5y	-93.37
Ch6m	-8.1
Change	-2.2%
Change From Open	-4.93
Close	0.66
Days Gap	2.88
Depreciation Amortization	302,000
Dollar Volume	81,763.5
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-22.1M
EBITDA	$-21.8M
EPS	$-1.23
F Score	3
FCF	$-18.4M
FCF EV Yield	-39.27x
FCF Per Share	$-0.24
Financing CF	16,633,000
Fiscal Year End	December
Founded	1,995
Investing CF	-179,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-23
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-23
Ma150	0.73
Ma150ch	-11.25%
Ma20	0.68
Ma20ch	-5.05%
Net CF	-1,744,000
Next Earnings Date	2026-05-22
Open	0.68
Optionable	No
Position In Range	31.06
Post Close	0.65
Postmarket Change Percent	0.02
Postmarket Price	$0.65
Ppne	1,921,000
Pre Close	0.66
Price Date	2026-05-08
Relative Volume	1.02x
Revenue	241,000x
SBC By Revenue	309.13x
Share Based Comp	745,000
Tr6m	-8.1%
Us State	Minnesota
Volume	126,667
Z Score	-59.67

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does COCH pay a dividend?

Capital-return profile for this ticker.

Performance

COCH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns COCH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.6%

Float: +59.5% of shares outstanding

Insider ownership

+37.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

COCH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.0

Neutral momentum band

Price vs 200-day MA

-25.1%

50/200-day relationship not available

Beta (5Y)

1.90

More volatile than the market

Sharpe ratio

0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About COCH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current COCH stock rating?

Envoy Medical, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full COCH analysis?

The full report lives at /stocks/COCH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for COCH?

The latest report frames COCH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the COCH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.